MAPT and Alzheimer disease: The results showed that all PS (p < 0.05), ADFH (p < 0.001), diabetes (p < 0.001), ESRD (p < 0.001) and OSA (p < 0.001) patients had significantly higher levels of plasma T-Tau than HCs but significantly lower levels than AD patients.